|
Characteristics
|
Age (years)
|
P-value
|
Total (unknown)
|
|---|
| |
≤ 40 n (%)
|
> 40 n (%)
| | |
|---|
|
Node Status
| | | |
838
|
|
Positive
|
159 (57.8)
|
320 (56.8)
|
0.7878
|
(29)
|
|
Negative
|
116 (42.2)
|
243 (43.2)
| | |
|
Tumor Size
| | | |
824
|
|
≤ 2
|
93 (32.3)
|
186 (32.1)
| |
(43)
|
|
3 – 5
|
155 (53.8))
|
320 (55.3)
|
0.8532
| |
|
≤ 5
|
40 (13.9)
|
73 (12.6)
| | |
|
Number of Nodes
| | | |
824
|
|
0
|
116 (42.3)
|
241 (43.1)
| |
(43)
|
|
1 – 3
|
83 (30.3)
|
178 (31.8)
|
0.6731
| |
|
4 – 10
|
51 (18.6)
|
104 (18.6)
| | |
|
> 10
|
24 (8.8)
|
36 (6.4)
| | |
|
Stage
| | | |
762
|
|
I
|
38 (15.0)
|
67 (13.1)
| |
(105)
|
|
II
|
170 (67.5)
|
347 (68.1)
|
0.7259
| |
|
III
|
44 (17.5)
|
96 (18.8)
| | |
|
Grade
| | | |
793
|
|
I
|
7 (2.6)
|
38 (7.2)
| |
(74)
|
|
II
|
130 (48.9)
|
297 (56.4)
|
0.0006
| |
|
III
|
129 (48.5)
|
192 (36.4)
| | |
|
Histopathology
| | | |
854
|
| | | | |
(13)
|
|
Infiltrating ductal
|
270 (98.5)
|
520 (93.2)
|
0.0009
| |
|
Infiltrating lobular
|
4 (1.5)
|
38 (6.8)
| | |
|
Lymph-Vascular Invasion
| | | |
702
|
|
Both Positive
|
84 (36.7)
|
159 (33.8)
|
0.4459
|
(165)
|
|
Both Negative
|
145 (63.3)
|
312 (66.2)
| | |
|
Hormonal Receptor Status
| | | |
677
|
|
ER+ PR+
|
99 (44.6)
|
252 (55.4)
|
0.0086
|
(190)
|
|
ER- PR-
|
69 (31.1)
|
99 (21.8)
| | |
|
ER+ PR-
|
13 (5.9)
|
39 (8.6)
| | |
|
ER- PR+
|
41 (18.5)
|
65 (14.3)
| | |
